This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0571U only for LiquidHALLMARK® ctDNA and ctRNA from Lucence Health Inc. This blood–based test evaluates 80 genes from circulating tumor DNA (ctDNA) and 10 genes from circulating tumor RNA (ctRNA) using next–generation sequencing (NGS). It identifies multiple types of genetic changes that may be important for treatment decisions. Results are reported as clinically actionable variants.
For clinical responsibility, terminology, tips and additional info
start codify free trial.